What evaluations and interventions can be offered after two 16-week spontaneous abortions, including one with a normal Non-Invasive Prenatal Test (NIPT) result and a twins In Vitro Fertilization (IVF) pregnancy, to understand the reason for the losses and prevent future occurrences?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evaluation and Management After Recurrent Spontaneous Abortions

After two 16-week spontaneous abortions, including one with normal NIPT and a twins IVF pregnancy, a comprehensive workup is strongly recommended to identify potential causes and prevent future pregnancy losses.

Diagnostic Evaluation Algorithm

1. Genetic Evaluation

  • Karyotyping of parents: Essential to identify potential chromosomal abnormalities, particularly translocations 1
  • Products of conception analysis: If available from previous losses, should be tested for chromosomal abnormalities (accounts for approximately 50% of spontaneous abortions) 2
  • Consider chromosomal microarray (CMA): For more detailed genetic analysis, especially recommended for smaller copy-number changes 1

2. Anatomical Assessment

  • Transvaginal ultrasound: To evaluate for uterine anomalies, fibroids, or other structural issues 1
  • Hysteroscopy or sonohysterography: To assess the uterine cavity for septum, adhesions, or other structural abnormalities

3. Immunological Evaluation

  • Antiphospholipid antibody testing: Including lupus anticoagulant, anticardiolipin antibodies, and anti-β2 glycoprotein I 3
  • Antinuclear antibody (ANA): Particularly important as ANA positivity is significantly higher in spontaneous pregnancies with recurrent losses (30.4%) compared to IVF pregnancies (5.3%) 4

4. Thrombophilia Screening

  • Inherited thrombophilias: Factor V Leiden, prothrombin gene mutation, protein C and S deficiency, antithrombin III deficiency 4
  • Acquired thrombophilias: Already covered in immunological evaluation

5. Endocrine Assessment

  • Thyroid function tests: TSH, free T4
  • Glucose metabolism: Fasting glucose, HbA1c
  • Polycystic ovary syndrome (PCOS) evaluation: If clinically indicated 3

6. Special Considerations for Twin IVF Pregnancy

  • Chorionicity determination: Critical for risk assessment in future twin pregnancies 1
  • Placental examination: If available from previous losses 1

Management Recommendations for Future Pregnancies

1. Pre-conception Care

  • Genetic counseling: Based on results of genetic testing
  • Optimization of modifiable risk factors: Smoking cessation, limiting alcohol consumption, weight management 3

2. For Future IVF Pregnancies

  • Consider preimplantation genetic testing for aneuploidy (PGT-A): Could reduce abortion risk by up to 29% in recurrent pregnancy loss patients 4
  • Single embryo transfer: To reduce complications associated with multiple gestations

3. Early Pregnancy Monitoring

  • Early and frequent ultrasound monitoring: Starting at 6-7 weeks to confirm viability
  • Serial beta-hCG measurements: If indicated based on symptoms

4. Twin Pregnancy Surveillance (if applicable)

  • Early determination of chorionicity: By 14 weeks gestation
  • For monochorionic twins: Begin surveillance at 16 weeks with fetal biometry every 2-3 weeks and assessment for twin-twin transfusion syndrome (TTTS) every 2 weeks 1
  • For dichorionic twins: Follow every 3-4 weeks if uncomplicated 1
  • Cervical length assessment: Via transvaginal ultrasound to evaluate risk for preterm delivery 1

Treatment Based on Identified Causes

  • Chromosomal abnormalities: Genetic counseling, consider PGT-A for future IVF cycles
  • Antiphospholipid syndrome: Low-dose aspirin plus prophylactic heparin
  • Uterine anomalies: Surgical correction if indicated
  • Thrombophilias: Anticoagulation therapy based on specific diagnosis
  • Endocrine disorders: Specific treatment based on diagnosis

Important Considerations and Caveats

  • A significant finding is that causes of recurrent miscarriage appear similar between spontaneous and IVF pregnancies, with identifiable factors in approximately 86% of cases 4
  • Late losses at 16 weeks suggest factors beyond early chromosomal issues - consider cervical insufficiency, placental problems, or immunological factors
  • Normal NIPT results reduce but do not eliminate the possibility of chromosomal abnormalities, as NIPT primarily screens for common trisomies 1, 5
  • For twin pregnancies, specialized monitoring is critical due to higher risks of complications, especially in monochorionic twins 1
  • The psychological impact of recurrent pregnancy loss should be addressed, as women are at increased risk for depression and anxiety for up to one year after spontaneous abortion 2

Remember that even with thorough investigation, approximately 12% of recurrent pregnancy losses remain unexplained 4, but proper evaluation significantly improves the chances of identifying treatable causes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of spontaneous abortion.

American family physician, 2005

Research

Contemporary issues for spontaneous abortion. Does recurrent abortion exist?

Obstetrics and gynecology clinics of North America, 2000

Research

Causes of recurrent miscarriage after spontaneous pregnancy and after in vitro fertilization.

American journal of reproductive immunology (New York, N.Y. : 1989), 2020

Guideline

Non-Invasive Prenatal Testing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.